![Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2021–22 | MMWR Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2021–22 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7142a2_COVID19FluVax_IMAGE_21Oct22_1200x675.jpg?_=83012)
Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2021–22 | MMWR
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
![COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/publications/2021/11/covid-19-vaccines-the-difference-between-the-third-dose-and-a-booster-dose-easy-read.png)
COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care
![CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department](http://cecilcountyhealth.org/wp-content/uploads/2022/09/Screenshot-2022-09-06-3.52.01-PM.png)
CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department
![Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA](https://www.fda.gov/files/Booster%20Infographic_D_Rev_010622_0.png)
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
![NSW Health on X: "COVID-19 booster shots are now available! If you're 18 years and over and it's been 6 months since you received your last primary dose of a COVID-19 vaccine, NSW Health on X: "COVID-19 booster shots are now available! If you're 18 years and over and it's been 6 months since you received your last primary dose of a COVID-19 vaccine,](https://pbs.twimg.com/media/FDJ0zN1WQAUlLCv.jpg)
NSW Health on X: "COVID-19 booster shots are now available! If you're 18 years and over and it's been 6 months since you received your last primary dose of a COVID-19 vaccine,
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh](https://www.ed.ac.uk/sites/default/files/styles/landscape_breakpoints_theme_uoe_mobile_1x/public/thumbnails/image/final_v0.3_vbp_booster_vbs_infographic_3.png?itok=dgJ-Kjqg)
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![Las personas mayores con la dosis de recuerdo de otoño 2022 pueden tener tres veces menos riesgo de muerte por Covid-19 - Plan de Vacunaciones de Andalucía (Andavac) Las personas mayores con la dosis de recuerdo de otoño 2022 pueden tener tres veces menos riesgo de muerte por Covid-19 - Plan de Vacunaciones de Andalucía (Andavac)](https://www.andavac.es/wp-content/uploads/2022/11/rates-covid-19.jpg)
Las personas mayores con la dosis de recuerdo de otoño 2022 pueden tener tres veces menos riesgo de muerte por Covid-19 - Plan de Vacunaciones de Andalucía (Andavac)
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet](https://www.thelancet.com/cms/asset/43c19cc3-58f4-41c4-8c50-86f1f443c0fb/gr1.jpg)
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet
![OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department](https://www.ochd.org/wp-content/uploads/2021/10/COVID-19-BOOSTER-SHOTS-2.jpg)
OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department
![Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7118a4-F-large.gif?_=74292)